AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01940341 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TDF Placebo
Description: Tablet administered orally once daily
Study NCT03459807 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anti-Hypertensive medications
Description: Use of standard Anti-Hypertensive medications
Study NCT03459807 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Anti-Hypertensive medications
Description: Use of standard Anti-Hypertensive medications
Study NCT03459807 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dry Weight Adjustment
Description: The participant's target post-dialysis dry weight is adjusted
Study NCT03459807 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Dry Weight Adjustment
Description: The participant's target post-dialysis dry weight is adjusted
Study NCT03552393 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mircera
Description: The initial dose of Mircera will be one of nine starting doses corresponding to the prefilled syringe strengths based on the total weekly erythropoiesis-stimulating agent (ESA) dose during the screening period.
Study NCT02009163 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate
Description: SDP489 30, 50, or 70mg capsule once per day (open-label and double-blind periods)
Study NCT02009163 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsule once per day (double-blind period)
Study NCT03081403 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Quantitative Sensory Testing
Description: Study of detection thresholds of vibration, cold and pain related to the heat in the dominant hand of the subjects through the QST.
Study NCT03011892 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ruxolitinib 1.5% Cream QD
Description: Ruxolitinib 1.5% cream QD
Study NCT03143335 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Retropectoral immediate breast reconstruction
Description: Immediate reconstruction with the implant placed in a standard fashion, i.e. retropectoral in combination with an acellular dermal matrix.
Study NCT03143335 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Prepectoral immediate breast reconstruction
Description: Immediate breast reconstruction with the implant placed prepectoral supported by acellular dermal matrix alone.
Study NCT03509376 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Suture repair
Description: The diastasis is repaired with continous nylon suture
Study NCT03509376 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Rolled mesh repair
Description: Continuous nylon suture is done over a narrow strip of self gripping Rolled mesh to repair the diastasis
Study NCT04262102 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: SD_SF
Description: Women will follow a personalized standard diet, described in National Diet Surveys. And their children will be spoon-fed during complementary feeding.
Study NCT04262102 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SD_BLW
Description: Women will follow a personalized standard diet, described in National Diet Surveys. And their children will follow a baby-led weaning approach for complementary feeding.
Study NCT04262102 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HFV_SF
Description: Women will follow personalized diet, high in fruits and vegetables. And their children will be spoon-fed during complementary feeding.
Study NCT04262102 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HFV_BLW
Description: Women will follow personalized diet, high in fruits and vegetables. And their children will follow a baby-led weaning approach for complementary feeding.
Study NCT05592535 — intervention group
Intervention type: PROCEDURE
Intervention: Coronary revascularization
Description: Coronary revascularization performed by PCI in a vessel investigated with FFR or indication for surgery
Study NCT03561727 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Mass closure technique
Description: Abdominal cavity will be closed by a single layer of 2 continuous sutures beginning on the opposite ends of the wound towards the median line and involving peritoneum, transversalis fascia, posterior and anterior layer of rectus abdominis muscle fascia and, in case of incisions beyond the lateral border of rectus abdominis muscle, also the oblique abdominal muscles fascia.
Study NCT03561727 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Layered closure technique
Description: he first layer will include peritoneum, transversalis fascia and posterior layer of the rectus abdominis muscle fascia closed with 2 continuous sutures beginning at both ends of the wound. In case of incisions exceeding the lateral border of rectus abdominis muscle, the second layer of the continuous suture will start at the lateral border of rectus abdominis muscle, process laterally to the lateral end of the wound involving internal oblique abdominal muscle fascia. Subsequently, the suture will be led out on the anterior surface of the external oblique abdominal muscle, put through by the created loop in the medial direction and processed medially to close the external oblique abdominal muscle fascia and anterior layer of the rectus abdominis muscle fascia.
Study NCT00652288 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin analogs (Lispro and Aspart)
Description: Insulin bolus given through insulin pump
Study NCT04024787 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioural therapy for insomnia (CBT-I)
Description: Participants with chronic primary insomnia are randomized into 2 groups with a 1:1 allocation ratio, after the completion of the pre-treatment assessment. Post-treatment and post-waitlist assessment occur after the 3-month treatment or waiting period.~One group will receive the intervention immediately after the pre-treatment assessment and the other group will receive the intervention after a waiting period of 3 months. The intervention consists of manualized cognitive-behavioural therapy for insomnia. This treatment includes psychoeducation about sleep and circadian rhythms, stimulus control, sleep restriction, relaxation, and cognitive therapy. The therapy is administered individually. Participants meet for 8 sessions of 50 minutes spread over 12 weeks.
Study NCT04430296 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cyclophotocoagulation
Description: High Intensity Focused Ultrasound Cyclophotocoagulation (HIFU): parameters: 21 MHz frequency, 2.45 W acoustic power, with the activation of each transducer lasting 6 seconds MicroPulse cyclophotocoagulation (MP-CPC):Laser settings of 2 Watts (W) will be applied for a 90 seconds treatment time for each 180 degrees, with a duty cycle of 31.3%, which consists of 0.5ms on time and 1.1 ms off-time and delivering a total of 112,7 Joules Continuous Wave cyclophotocoagulation (CW-CPC): The laser settings used will be 1.250 W, 4s exposure time per burn, 22-24 burns per eye.
Study NCT03904680 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methotrexate
Description: Methotrexate 2.5 mg tablet
Study NCT00652288 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin analogs (Aspart and Detemir)
Description: Drugs given separately
Study NCT03570593 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: REMOVAL OF URINARY CATHETER AFTER RADICAL SURGERY
Description: Removal of urinary catheter on the first day after radical surgery
Study NCT03594552 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Arbaclofen_15
Description: Single oral dose (15mg)
Study NCT00652288 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin analogs (Aspart and Detemir)
Description: Drugs given in the same injection
Study NCT01638468 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AngioJet Ultra PE Thrombectomy System
Description: Thrombectomy with or without lytic delivery using the AngioJet Ultra PE Thrombectomy System
Study NCT03786094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eribulin
Description: Eribulin alone
Study NCT03786094 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Eribulin
Description: Eribulin alone
Study NCT03011892 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ruxolitinib 1.5% Cream BID
Description: Ruxolitinib 1.5% cream BID
Study NCT03011892 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ruxolitinib 1.5% Cream BID
Description: Ruxolitinib 1.5% cream BID
Study NCT03011892 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ruxolitinib 1.5% Cream BID
Description: Ruxolitinib 1.5% cream BID
Study NCT03011892 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Triamcinolone 0.1% Cream BID
Description: Triamcinolone 0.1% cream BID
Study NCT03011892 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vehicle Cream BID
Description: Vehicle cream BID
Study NCT03011892 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle Cream BID
Description: Vehicle cream BID
Study NCT03240744 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Inactivated EV71 vaccine (human diploid cell, KMB-17)
Description: 3.0 EU of inactivated enterovirus 71 vaccine (KMB-17) on day 0, 28.
Study NCT02102503 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard Treatment
Study NCT02102503 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Treatment
Study NCT02102503 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MI and Medication review
Study NCT02671916 — intervention group
Intervention type: BEHAVIORAL
Intervention: questionnaire
Description: Investigation on all study patients, no Intervention, no groups
Study NCT03381729 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Onasemnogene Abeparvovec-xioi
Description: Self-complementary AAV9 carrying the SMN gene under the control of a hybrid CMV enhancer/chicken-β-actin promoter
Study NCT02472509 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic Acid
Description: Patients will be commenced on UDCA 15mg/kg/day (maximum dose 900mg/day) in 2-3 divided doses for 12 months.~Patients who are unable to tolerate tablet medication will be started on UDCA syrup at the same dose.
Study NCT02442401 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The negative pressure wound therapy
Study NCT03120455 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Almond Group
Description: Obese or overweight female adults will be randomly allocated to have almond as afternoon snacks, while they have a hypoenergetic diet.
Study NCT03120455 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Pistachio Group
Description: Obese or overweight female adults will be randomly allocated to have Pistachio as afternoon snacks, while they have a hypoenergetic diet.
Study NCT03120455 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Nut free group
Description: Obese or overweight female adults will be asked to avoid nuts, seeds and nut products, while they have a hypoenergetic diet.
Study NCT01552733 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 'Inmotion Arm Robot'
Description: To improve limb function in those with limb impairment
Study NCT01552733 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard of care
Description: Rehabilitation Therapy
Study NCT02292901 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Macintosh laryngoscope
Study NCT02292901 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: McGrath Mac videolaryngoscope
Study NCT03786094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Balixafortide
Description: Balixafortide + Eribulin
Study NCT04081519 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: active rTMS over DLPFC
Description: 15 sessions of active rTMS over DLPFC
Study NCT03904680 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D
Description: Vitamin D 200,000 IU ampules
Study NCT01133743 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide and Dexamethasone
Description: Starting Lenalidomide dose 2.5 mgs or 5 mgs (based on baseline calculated creatinine clearance)PO daily on a 28 day cycle. Dose escalations will take place at the start of subsequent cycles as frequently as tolerated but not more frequently than at the start of each cycle to a target dose of 25mg daily. Oral dexamethasone at 12 mg PO daily will be administered on days 1-7, 14 and 21 of each cycle
Study NCT01296906 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Recall conducted by private practices
Description: All practices in these counties will receive training on practice-based R/R using the Colorado Immunization Information System (CIIS or immunization registry). Practices will receive a recommended schedule for conducting recall in 19-35 month children and educational materials to use within their practices to promote compliance with the infant vaccination schedule. Individual practices will make their own decisions about the extent to which they follow the recommendations and implement recall within their practice. Although the study team will not provide them with any additional interventions, we will track any other interventions they independently do (websites, newsletters, telephone informational systems) in order to assess the effect of these additional interventions.
Study NCT01296906 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Recall conducted centrally by local health department
Description: A centralized recall of children 19-35 months will be conducted through local health departments. CIIS will identify a cohort of 19-35 month olds with an who are in need of an immunization and will coordinate up to 3 mailers to children who are not current for recommended immunizations.
Study NCT01644877 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DAS181 dry powder, formulation F02
Study NCT01644877 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Lactose Placebo
Study NCT04268030 — intervention group
Intervention type: OTHER
Intervention: collection of LFPs
Description: collection of local field potentials (LFPs) at rest and during hand opening and closing
Study NCT03202654 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Corn Oil
Description: 4 tablespoons/day of corn oil for 4-week treatment period.
Study NCT03202654 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Coconut Oil
Description: 4 tablespoons/day of coconut oil for 4-week treatment period.
Study NCT04161040 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Performance-based incentives
Description: Participants will earn $1 per minute of engagement in physical activity.
Study NCT01526148 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lithium
Description: Lithium will be initiated at 300 mg per day and titrated in 300 mg increments every 7days as tolerated with blood lithium levels > 0.6mEq/L.
Study NCT01526148 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Quetiapine
Description: Quetiapine will be started at 50 mg per day at bedtime and titrated up to 300 mg as tolerated over 1 week.
Study NCT05344547 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiac risk ratio (CRR)
Description: Cardiac risk ratio (CRR) was calculated according to Genest et al. (23) as serum total cholesterol (TC) level divided by serum high-density lipoprotein-cholesterol (HDL-c) level and woman with CRR at ≥3.5 was considered at risk of cardiac disease (24).
Study NCT02298101 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Technetium-99m - Diethylenetriaminepentaacetic acid
Description: Solution placed on the nebulizer reservoir
Study NCT02298101 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Aeroneb Solo Adapter
Description: Nebulizer
Study NCT02298101 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Opti-Mist Plus Nebulizer
Description: Standard jet nebulizer
Study NCT02298101 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Planar scintigraphy
Description: Imaging technique to investigate whole lung deposition
Study NCT02298101 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Single photon emission computed tomography
Description: Imaging technique to investigate regional pulmonary deposition
Study NCT00652288 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin analogs (Lispro and Glargine)
Description: Drugs given separately
Study NCT00652288 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin analogs (Lispro and Glargine)
Description: Drugs given in single injection
Study NCT01926821 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sonifilan
Description: Sonifilan inj 20mg Intra muscular injection, twice per week for 8 weeks, total 16 times
Study NCT04081519 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: active rTMS over DLPFC
Description: 15 sessions of active rTMS over DLPFC
Study NCT04081519 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: active rTMS over DLPFC
Description: 15 sessions of active rTMS over DLPFC
Study NCT04081519 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Add-on active rTMS over DLPFC
Description: 15 additional sessions of active rTMS over DLPFC
Study NCT03037697 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TheraTogs Arm
Description: TheraTogs Arm Received Soft Orthotic undergarments
Study NCT03037697 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional Treatment
Description: Traditional treatment to Dyskinetic CP~1- Trunk control exercises 2- Core stability training 3- Proximal dynamic stability for the shoulder and pelvic girdles components. 4- Back and abdominal strengthening exercises 5- Standing exercises : - Standing alone gradually increase time. - Stride standing alone. - Step standing alone (other limb supported on wooden step then soft step and finally on small ball). - Standing on balance board
Study NCT04081519 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Add-on active rTMS over LPC
Description: 15 additional sessions of active rTMS over LPC
Study NCT03037697 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Treatment
Description: Traditional treatment to Dyskinetic CP~1- Trunk control exercises 2- Core stability training 3- Proximal dynamic stability for the shoulder and pelvic girdles components. 4- Back and abdominal strengthening exercises 5- Standing exercises : - Standing alone gradually increase time. - Stride standing alone. - Step standing alone (other limb supported on wooden step then soft step and finally on small ball). - Standing on balance board
Study NCT04513418 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Preoperative immunonutrition
Description: Preoperative immunonutrition includes an omega-3 fatty-acid enriched enteral nutritional emulsion given by oral intake, nasogastric feeding tube or jejunostomy 600ml per day, lasting for the whole period of neoadjuvant chemoradiation. Meanwhile, oral intake is encouraged to reach 25-30kcal/kg through regular food.
Study NCT03782779 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Breathing program and regular exercise
Description: This program will be supervised by a physical therapist and will include learning and performing a diaphragmatic-abdominal breathing, and incorporating the new breathing pattern to a upper and lower limbs regular exercises as well as to daily life activities.
Study NCT03782779 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Regular Exercise
Description: Regular upper and lower limbs exercises supervised by a physical therapist
Study NCT01547377 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: zinc and selenium supplementation
Description: Data from patients were obtained at beginning and after four months of treatment with 10 mg rosuvastatin, concomitantly with zinc (30mg/d) and selenium (150μg/d) supplementation or placebo. The anthropometric and dietary data, zinc and selenium concentrations in plasma and erythrocyte, lipid profile, electronegative LDL (LDL(-)), anti- electronegative LDL, Ac-LDL(-) immune complexes, GPx and SOD activities, IL-6 and hs-CRP were evaluated in all patients
Study NCT01547377 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: rosuvastatin + placebo
Description: Data from patients were obtained at beginning and after four months of treatment with 10 mg rosuvastatin, concomitantly with zinc (30mg/d) and selenium (150μg/d) supplementation or placebo. The anthropometric and dietary data, zinc and selenium concentrations in plasma and erythrocyte, lipid profile, electronegative LDL (LDL(-)), anti- electronegative LDL, Ac-LDL(-) immune complexes, GPx and SOD activities, IL-6 and hs-CRP were evaluated in all patients